User profiles for Sebastian Havervall
 | Sebastian HavervallMD, Danderyd Hospital, Karolinska Institutet Verified email at ki.se Cited by 2170 |
[HTML][HTML] SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden
AS Rudberg, S Havervall, A Månberg… - Nature …, 2020 - nature.com
SARS-CoV-2 may pose an occupational health risk to healthcare workers. Here, we report
the seroprevalence of SARS-CoV-2 antibodies, self-reported symptoms and occupational …
the seroprevalence of SARS-CoV-2 antibodies, self-reported symptoms and occupational …
Symptoms and functional impairment assessed 8 months after mild COVID-19 among health care workers
Methods| The COMMUNITY (COVID-19 Biomarker and Immunity) study investigates long-term
immunity after mild COVID-195 (eMethods in the Supplement). Between April 15, 2020, …
immunity after mild COVID-195 (eMethods in the Supplement). Between April 15, 2020, …
[HTML][HTML] Anti-spike mucosal IgA protection against SARS-CoV-2 omicron infection
S Havervall, U Marking, J Svensson… - … England Journal of …, 2022 - Mass Medical Soc
Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection | NEJM Skip to main
content NEJM Group Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare to …
content NEJM Group Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare to …
[HTML][HTML] Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2
S Havervall, U Marking, N Greilert-Norin, H Ng… - …, 2021 - thelancet.com
Background Recent reports demonstrate robust serological responses to a single dose of
messenger RNA (mRNA) vaccines in individuals previously infected with SARS-CoV-2. Data …
messenger RNA (mRNA) vaccines in individuals previously infected with SARS-CoV-2. Data …
Patients with COVID-19 have elevated levels of circulating extracellular vesicle tissue factor activity that is associated with severity and mortality—brief report
A Rosell, S Havervall, F von Meijenfeldt… - … and Vascular Biology, 2021 - Am Heart Assoc
Objective: Patients with coronavirus disease 2019 (COVID-19) have a high rate of thrombosis.
We hypothesized that severe acute respiratory syndrome coronavirus 2 infection leads to …
We hypothesized that severe acute respiratory syndrome coronavirus 2 infection leads to …
Circulating markers of neutrophil extracellular traps are of prognostic value in patients with COVID-19
H Ng, S Havervall, A Rosell, K Aguilera… - … , and vascular biology, 2021 - Am Heart Assoc
Objective: The full spectrum of coronavirus disease 2019 (COVID-19) infection ranges from
asymptomatic to acute respiratory distress syndrome, characterized by hyperinflammation …
asymptomatic to acute respiratory distress syndrome, characterized by hyperinflammation …
[HTML][HTML] SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection
Current SARS-CoV-2 serological assays generate discrepant results, and the longitudinal
characteristics of antibodies targeting various antigens after asymptomatic to mild COVID-19 …
characteristics of antibodies targeting various antigens after asymptomatic to mild COVID-19 …
Impact of SARS‐CoV‐2 infection on vaccine‐induced immune responses over time
S Havervall, U Marking, N Greilert‐Norin… - Clinical & …, 2022 - Wiley Online Library
Objective To determine the long‐term impact of prior SARS‐CoV‐2 infection on immune
responses after COVID‐19 vaccination. Methods Using longitudinally collected blood samples …
responses after COVID‐19 vaccination. Methods Using longitudinally collected blood samples …
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID‐19
S Havervall, H Ng, A Jernbom Falk… - Journal of internal …, 2022 - Wiley Online Library
Background Emerging data support detectable immune responses for months after severe
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection and vaccination, but it is …
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection and vaccination, but it is …
Sustained prothrombotic changes in COVID-19 patients 4 months after hospital discharge
FA von Meijenfeldt, S Havervall, J Adelmeijer… - Blood …, 2021 - ashpublications.org
Patients with COVID-19 are at increased risk of thrombotic complications, despite the in-hospital
use of standard-or escalated-dose thromboprophylaxis. 1-3 As a result, numerous …
use of standard-or escalated-dose thromboprophylaxis. 1-3 As a result, numerous …
